MemoryPlus
Cognition Restoring Treatment for Alzheimer’s Disease
StartupMemoryPlus is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2019. Cognition Restoring Treatment for Alzheimer’s Disease. MemoryPlus was founded by Shira Knafo. Key investors include Israel Biotech Fund. The company has 1-10 employees.
The company follows a B2B business model. Product stage: R&D.
- StagePre-Seed
- ProductR&D
- ModelB2B
- Employees1-10
- HQRehovot
- DistrictCenter District
- Last RoundUndisclosed
- Israel Biotech FundLead
Shira KnafoCSO
What does MemoryPlus do?
MemoryPlus is pioneering an innovative treatment targeting Alzheimer’s-related cognitive decline, leveraging a novel mechanism of action (MOA). Its research is based on groundbreaking work from Prof. Shira Knafo, who discovered that the PTEN protein plays a critical role in memory decline by inhibiting neuronal activity. By disrupting the interaction between PTEN and PDZ domain proteins, the company has the potential to restore memory function.
Who founded MemoryPlus?
MemoryPlus was founded in 2019 by Shira Knafo (CSO).
What sector is MemoryPlus in?
MemoryPlus operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is MemoryPlus located?
MemoryPlus is based in Rehovot, Israel, Center District.